Nov 30, 2022 / 07:50PM GMT
Phil Dantoin - Piper Sandler & Co. - Analyst
All right, everybody. I guess some interesting time here. We'll get started here. My name is Phil Dantoin. I work here on Piper's MedTech team. I'm very excited to have LENSAR here with us today. And here from the company is Chief Executive Officer, Nick Curtis. So with that, I'll pass it over to Nick. Very (inaudible).
Nick Curtis - LENSAR Inc. - CEO
Yeah. First off, I'd like to thank the Piper team as well as Matt for inviting LENSAR to present today. As Phil said, I'm Nick Curtis. I am the CEO of LENSAR. I appreciate you taking the time to listen to the presentation, and I look forward to telling you a little bit about LENSAR and what we're doing in this market, the markets that we serve. Please review the information on the slide two regarding any forward-looking statements that I make in the presentation. Our SEC filings can be accessed on our website.
LENSAR is a technology leader. We're in the premium femtosecond laser-assisted cataract surgery market. We've got a surgeon centric culture, and we're
LENSAR Inc at Piper Sandler Healthcare Conference Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers